Jul, 2012
News / Press Releases
Enzalutamide Granted Priority Review by U.S. FDA for the Potential Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated with Chemotherapy (pdf 53KB)
Read More
News / Press Releases
Addition of Tarceva® (erlotinib) to Nexavar® (sorafenib) did not Provide Additional Benefit to Patients with Unresectable Liver Cancer Versus Nexavar alone in Phase 3 Trial (pdf 154KB)
Read More
Apr, 2024
Apr, 2024
Feb, 2024
Nov, 2023
Mar, 2024
Feb, 2024
Oct, 2023
Sep, 2023
Nothing Found
Unfortunately, we weren't able to find a match for your search query. Please try again.
Nothing Found
Unfortunately, we weren't able to find a match.